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response of potentially precancerous oral mucosal lesions 
(Under the direction of Ricardo Padilla)  
  
Objective: Identify the type and distribution of CD4+ and CD8+ T-lymphocytes in oral 
mucosa specimens to potentially distinguish underlying alterations or patterns between oral 
epithelial dysplasia and oral lichen planus. 
Methods: For this pilot study, 15 archival tissue samples received at UNC Oral and 
Maxillofacial Pathology Laboratory, diagnosed as oral lichen planus, moderate to severe 
epithelial dysplasia and overlapping equivocal cases between dysplasia and lichen planus 
were selected. Dual staining with CD4 and CD8 antibodies was carried out on each case. 
Slides were scanned in the Aperio ScanScope FL (Leica Biosystems, Wetzlar, Germany) and 
archived. Histomorphometric analysis of the cells that expressed biomarkers of in the 
epithelium and connective tissue regions was performed.  
Results: No differences were found in amount and ratio of CD4+/CD8+ lymphocytes 
between the three groups analyzed. The intraepithelial CD8+ lymphocyte distribution was 
strikingly different between lichen planus and moderate to severe epithelial dysplasia.  
Conclusions: The localization of CD8+ cells can be potentially as an adjunctive 
diagnostic procedure to distinguish oral epithelial dysplasia from other inflammatory entities 
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The oral cavity is lined by mucosa comprised of stratified squamous epithelium and 
supporting connective tissues. Clinical lesions in the oral mucosa often present as 
pathognomonic changes, such as geographic tongue or Fordyce granules. Frequently, 
however, and sometimes as non-specific areas of red, white, ulcerated mucosa, or 
combination of these that require pathologic examination for diagnosis. The majority of the 
time, lesions examined histologically by pathologists will exhibit enough features to reach a 
specific diagnosis.  Occasionally, some lesions have similar histologic architectural alterations 
in the presence of inflammation of different etiologies such as trauma, allergic reactions, 
autoimmune diseases, and infectious diseases.  Some lesions can also show a similar 
inflammatory response when undergoing malignant transformation. Lichen planus (LP) and 
oral epithelial dysplasia (OED) are entities with different etiology, treatment and prognosis, 
but sometimes they can share similar or overlapping histopathologic features as described 
above (1).  
Oral Leukoplakia 
Oral leukoplakia is a clinical term used to describe a mucosal lesion that exhibits a 
white surface that does not rub off and is not diagnosable clinically as a specific disease.  Upon 
histological evaluation, these are usually diagnosed as either hyperkeratosis, epithelial 
dysplasia, squamous cell carcinoma (SCC), lichen planus, oral hairy leukoplakia, etc.  Oral 
leukoplakia has a worldwide prevalence of 2%, which represents the most common “risk” 
lesions for the oral mucosa, with annual overall malignant transformation rates ranging from 
0.7% to 2% in various populations and geographical areas. Therefore, surveillance of 
precursor lesions is an ongoing challenge in many healthcare systems(1). Despite progress 
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in the understanding of basic mechanisms involved in malignant transformation and 
substantial improvements in molecular diagnostics, there is no single marker or panel of 
markers available yet, that allow for reliable prediction of malignant transformation of 
leukoplakia for the individual patient.  Therefore, it is recommended that all leukoplakias 
undergo histologic examination for final and precise diagnosis (1). 
Biology of Oral Lichen Planus 
The initial clinical description of lichen planus is generally attributed to Ferdinand Ritter 
von Hebra, who in 1860 termed the condition “lichen ruber planus”(2).  He is credited with the 
first scientific description of the disease on the skin. Lichen planus obtained its name because 
of the lacy white lines that bear a close resemblance to the symbiont, lichen, a composite 
organism consisting of a fungus and a photosynthetic partner living together in a symbiotic 
relationship, seen growing on rocks and trees. However, Ferdinand Ritter von Hebra used the 
term lichen to denote skin lesions which are characterized by a macular-papular skin eruption. 
Louis Wickham is acknowledged as the first to describe the characteristic, fine, white or grey 
lines known as Wickham striae or dots seen on the top of the pruritic papular rash of lichen 
planus of the skin.  Wickham striae are also seen in oral LP. (3,4) 
The oral mucosa appears to have a limited immunological repertoire, predominantly a 
lichenoid-type reaction(5). This is characterized by delayed type IV hypersensitivity reaction, 
dominated by cytotoxic cluster of differentiation 8 positive (CD8+) T-lymphocytes inducing 
apoptosis of the basal keratinocytes.  It represents the final common immunopathological 
pathway secondary to a variety of insults, such as the development of autoantibodies against 
self-antigens, interaction with allergens such as various drugs or dental materials, viruses 
such as Hepatitis C, mechanical and chemical trauma, and even emotional stress(6). 
However, the specific pathophysiology, including the precise triggering factors, remain 
unknown and elusive.  
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The antigen that serves as the trigger and/or driver of the immune responses seen in 
idiopathic oral lichen planus is unknown. It is likely to be an endogenous peptide or a protein 
sequence innate to the basal keratinocytes; therefore, LP can be characterized as an 
autoinflammatory condition(1). It is also likely that the supposed exogenous triggers for oral 
LP, such as dental materials, flavoring agents, certain drugs, viruses and even trauma serve 
to expose such self-antigens, or, alter the normal innate peptide sequences so that they are 
perceived by the immune-surveillance cells as being “foreign” or as antigenic targets(5,7). The 
immune responses to this, as yet, unidentified antigen develops in three stages: T-cell 
migration to the epithelium, T-cell activation, and induction of apoptosis of the basal 
keratinocytes.  
T-Cell Migration into the Epithelium 
Two hypotheses have been proposed to explain the migration of T-cells into the 
epithelium. The “chance encounter” hypothesis suggests that normally circulating, antigen-
specific CD8+ cytotoxic T-cells enter the epithelium for routine surveillance and by chance 
encounter the putative antigen when it is present in the epithelium (8,9). Alternatively, the 
keratinocytes direct the CD8+ cytotoxic cells to migrate into the epithelium by the release of 
cytokines that allow the lymphocytes to “home-in” on the antigen-bearing basal keratinocyte, 
the so called “direct migration” hypothesis (10).  
T-Cell Activation 
The lymphocytic infiltrate that histologically characterizes the oral LP lesions is 
comprised predominantly of T-cells (5,10). The majority of the T-cells in proximity to the 
damaged and dying basal keratinocytes and within the epithelial layers are predominantly 
activated cytotoxic CD8+ T-cells(6). Cytotoxic CD8+ T-cells bind to the antigen on the major 
histocompatibility complex Class I (MHC) site of keratinocytes, which releases cytokines that 
attract other lymphocytes and immune cells into the site of the developing LP lesion. The CD8 
+T-cells are also activated by the CD4+ helper cell found in the lamina propria. In oral LP 
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lesions, helper CD4+ T-cells are also activated by antigens associated with Class II MHC 
presented by the antigen-presenting cells or Langerhans cells, or by the keratinocytes 
themselves, which are induced to present antigens on their Class II MHC sites (1,11,12). 
Langerhans cells are increased in number in oral LP lesions and also have up-regulated Class 
II MHC expressing Langerhans cells and keratinocytes which in turn promote CD4+ T-cell 
secretion of cytokines interleukin-2 (IL-2) and interferon-ϒ (IFN- ϒ) (9,13). These cytokines 
and probably others, together with the presentation of an antigen associated with MHC class 
I on basal keratinocytes, promote cytotoxic CD8+ T-cell induction of apoptosis in keratinocytes 
(14,15). Hence, it is likely that in oral LP there is a cycle of self-inducting and self-perpetuating 
T-lymphocyte activation.  
Basal Keratinocyte Apoptosis 
The apoptosis of the basal keratinocytes that characterizes all forms of LP, is mediated 
predominantly by hyperactive, cytotoxic CD8+ T-cells(16). It has been previously reported that 
in patients with cutaneous LP, the T-cells are usually more cytotoxic and active than T-cells 
present in non-lesional areas of the skin(17,18). Also, it has been shown that the most 
cytotoxic T-cell clones were CD8+ and the least cytotoxic were CD4+. This finding also 
indicates that the apoptosis of the basal keratinocytes so characteristic of cutaneous and oral 
LP is induced by the cytotoxic CD8+ T-lymphocytes activated by a putative basal keratinocyte 
antigen associated with the MHC class I(5,13,19). 
The induction of keratinocyte apoptosis by CD8+ T-cells in LP and oral LP can occur 
by three established pathways:  
1. T-cell secretion of tumor necrosis factor-alpha (TNF-) which binds TNF-α 
receptor 1 on the keratinocyte surface. 
2. T-cell surface expression of CD95L (Fas ligand), which binds CD95(Fas) on 
the keratinocyte surface.  CD95L is a type-II transmembrane protein that 
belongs to the TNF family that in binding with its receptor induces apoptosis in 
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the target cells. Fas-induced apoptosis by the perforin pathway are the two 
main mechanisms by which cytotoxic T-lymphocytes induce cell death in cells 
expressing foreign antigens. 
3. Infusion of granzyme B by T cells into the keratinocytes. Granzymes are serine 
proteases that are released from cytoplasmic granules within cytotoxic T-cells 
and natural killer cells (NK cells).  Granzyme B induces apoptosis within virus-
infected cells. Cytotoxic T-cells release X perforin, a protein that attacks the 
target cells by forming a multimeric complex that enters cells through the 
mannose 6-phosphate receptor. Granzyme B is released to cause apoptosis 
by various pathways, including the cleaving of caspases (especially caspase-
3), which in turn activates caspase-activated DNase and this enzyme degrades 
DNA, therefore inducing the apoptotic cascade culminating in cell 
death(6,10,13).   
Malignant transformation of Oral Lichen Planus 
There is a small chance of malignant transformation in patients with lichen planus, 
particularly in patients with either the erosive or so-called plaque-type form(20,21).  Ever since 
the first clinical report about malignant transformation in LP was published in 1924, there has 
been an unresolved controversy regarding whether LP should be considered a premalignant 
condition (22–24). To this date, the reported malignant transformation varies from 0.4% to 
12.5% with an overall average rate of 1.09% cited in a recent meta-analysis and systematic 
review of 7,806 patients in 16 studies, making the World Health Organization (WHO) 
categorize these lesions as premalignant (25,26). However, the majority of the studies have 
not shown evidence of premalignant potential as convincing, consistent, or conclusive as that 
characterizing OED (27,28). Besides OED, many other disorders clinically and 
histopathologically can resemble lichen planus in the oral cavity.  
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A currently favored explanation for the transformation of oral LP into SCC is that the 
inflammatory infiltrate underlying the surface epithelium is affected by the release of cytokines 
associated with oxidative stress, which, in turn, activate transcription factors in the epithelial 
cells with premalignant potential (6,29).  A variety of scenarios may lead to a clinical and 
histologic presentation of lichenoid mucositis (LM), including local or systemic allergy, 
immune-related disease including LP, chronic ulcerative stomatitis and dysplastic oral lesions 
(30). One point not yet determined is whether the proposed mechanism for transformation 
could be applied to all etiologies of lichenoid lesions or whether it applies only to 
classic/idiopathic oral LP (31). In the case of dysplastic oral lesions eliciting a lichenoid 
response, if this model is applicable, it would seem that the lichenoid response in an already 
premalignant lesion could exacerbate and accelerate the progression to SCC. To date, it is 
unclear whether oral LP is an independent risk factor for malignant transformation.  
Numerous studies have also investigated various mechanisms involved in 
carcinogenesis including P53 mutation, PCNA mutation, loss of heterozygosity at the tumor 
suppressor gene loci, and cytogenetic abnormalities (32–35). None of the data shows 
convincing or consistent findings about the premalignant potential of oral lichen planus. The 
inflammatory infiltrate associated with oral lichen planus has been proposed to be a 
mechanism for malignant transformation (36). This proposal has some merits as other chronic 
inflammatory diseases have also been linked to cancerous transformation such as colon 
cancer in long-standing inflammatory bowel disease precipitated by intestinal microflora, and 
Barret’s esophagitis (37). Conversely, other data suggests that inflammatory and immune 
systems may inhibit tumorigenesis (38).    
The histopathologic features of lichen planus fall on a spectrum, potentially influenced 
by the stage of the disease at the time of the biopsy, recent therapy of the condition, the clinical 
types and/or the anatomic sites of involvement. Oftentimes, biopsies of OED can mimic oral 
LP on low magnification, exhibiting a prominent band-like chronic inflammatory infiltrate 
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subjacent to the basal keratinocytes (30,39,40). This inflammatory infiltrate may be there in 
an attempt to inhibit tumorigenesis progression.  
Oral Lichen Planus vs Epithelial Dysplasia 
Various disorders may present with clinical and histopathologic features similar to oral 
LP (41,42). Although oral epithelial dysplasia usually presents as a solitary lesion with variable 
proportions of white and red color change and ulceration, multifocal presentation is well 
recognized as seen, for example, in patients with advanced tobacco-related mucosal injury 
and proliferative verrucous leukoplakia (43).  
Oral epithelial dysplasia is usually associated with a band-like chronic inflammatory 
cell infiltrate in the superficial lamina propria which, when viewed with low-magnification 
microscopy, may offer substantial histopathological mimicry of LP(29). In 1985, the term 
“lichenoid dysplasia” was introduced to differentiate cases of epithelial dysplasia exhibiting 
lichenoid inflammation from oral lichen planus(44). This term was eventually discontinued and 
due to the ambiguity generated when rendering a straightforward diagnosis. Considerable 
clinical and histologic overlap has been found between LP and OED of the oral cavity, 
especially with the entity called proliferative verrucous leukoplakia, raising the question of 
whether the cases of oral LP that purportedly transform to SCC in fact represent undetected 
premalignant lesions with a nonspecific inflammatory response that mimics oral LP (37,45). 
The incidence of lichenoid features in OED and OSCC has been investigated by Fitzpatrick et 
al. (2014)(25), in which lichenoid features were found, at least focally, in 29% of 352 dysplasia 
or SCC cases. In the cases that showed lichenoid features, band-like inflammatory cell 
infiltration, of mostly lymphocytes, and basal keratinocyte degeneration were the most 
frequent features encountered, accounting for 74% and 30% of the lichenoid features, 
respectively(29).  
There are still no widely accepted diagnostic criteria for LP. Microscopic differentiation 
of OED from LP is based on recognition of cytologic atypia in squamous epithelial cells and 
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identification of disturbance in the maturation pattern in cases of dysplasia, and their absence 
in LP(25). However, discrimination of mild epithelial dysplasia, with chronic interface 
mucositis, from LP, with reactive cellular atypia, can be challenging, requiring subjective 
assessment of ostensibly objective morphologic features(39,46). The WHO 2017 criteria do 
not address a way to distinguish or exclude OED from oral LP diagnosis(47).  
Little has been written concerning the frequency of individual lichenoid characteristic 
in dysplastic lesions, although Krutchkoff and Eisenberg(44) argued that the presence of 
liquefactive degeneration of the basal membrane of the epithelium was rarely noted in 
dysplastic lesions and may serve to differentiate such lesions from non-dysplastic LM.  
Nonetheless, they also warned that this was not always the case and that the presence of 
atypical features should overrule any lichenoid feature that might be coincident (29).  
Considerations about the Microscopic Diagnosis of Oral Epithelial Dysplasia 
The efficacy of microscopic identification and grading of precursor lesions as an 
indicator of potential malignant transformation has long been contested in the literature. 
Current evidence recognizes carcinogenesis of the epithelium as a multistep, progressive, 
cumulative process of genetic mutations that culminate in tumor formation and ultimately 
invasion and metastasis(48). Although transformation into oral cancer is not linear in its 
development, there is general agreement that it begins as epithelial hyperplasia and 
progresses through dysplasia, with more severe dysplastic changes signifying more extensive 
genetic aberrations(43,49). The timeframe for this process is not known, but it is thought to be 
a relatively slow process, with malignant transformation occurring within 10 years(49,50). 
Although this model may suggest that oral SCC is an inevitable conclusion to OED, this is not 
the case, even in the absence of definitive surgical intervention(51). Conversely, malignant 
transformation may occur despite active treatment and follow-up of mucosal lesions exhibiting 
dysplastic changes(51).   
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The diagnosis of epithelial dysplasia is often predicated on a combination of 
architectural and cellular abnormalities. Cellular abnormalities include proliferation of 
immature or atypical-appearing keratinocytes in the basal and parabasal areas of the oral 
epithelium as well as nuclear pleomorphism, high nuclear-to-cytoplasm ratio, increased 
mitotic activity, and hyperchromatism in individual cells (52). Architectural abnormalities 
include irregular epithelial stratification, elongated rete ridges extending into the submucosa 
(43), and loss of normal maturation, characterized by increased cellular density in the 
superficial epithelium, crowding of cells, and loss of polarity especially in the basal zone(30).  
The diagnostic dilemma between lichen planus and epithelial dysplasia appears to 
have more implications than the overlapping histopathologic features that can make the 
diagnosis difficult for the pathologist. Absence of broad consensus regarding the diagnostic 
criteria has been identified as the major obstacle to assuring the validity of studies 
investigating the potential of oral LP to undergo malignant transformation. This lack of 
diagnostic criteria becomes a problem for pathologists when evaluating cases with 
overlapping features between LP and OED, especially because the management of these 
condition is significantly different. A patient diagnosed with symptomatic LP will often be 
prescribed steroids or immunomodulators that will inhibit the inflammatory reaction targeting 
the superficial oral mucosa. In contrast, when a diagnosis of OED is made, a surgical resection 
of the lesion and close clinical follow-up is recommended as well as avoidance of topical 
steroids or other medications that may suppress the immunosurveillance of the area.  
New diagnostic techniques in pathology are focusing on the inflammatory response 
induced by the neoplasm, instead the tumor itself, to distinguish similar neoplastic entities, for 
early diagnosis of cancer in premalignant lesions, prognostic value, etc. This can be 
accomplished by evaluating and targeting lymphocytes specialized in orchestrating and 
regulating the immune cells and the immunosurveillance against malignant transformation.   
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In this study, we utilize immunohistochemical antibody phenotyping of the CD4+ and 
CD8+ T-lymphocytes within the inflammatory response in oral mucosal samples in order to 



























AIMS AND OBJECTIVES 
Objective  
Identify the type and distribution of CD4+ and CD8+ T-cells in oral mucosa specimens 
to potentially distinguish underlying alterations or patterns between oral epithelial dysplasia 
and oral lichen planus.  
Null Hypothesis: there are no statistical significant differences between the presence 
and distribution of subtypes of T-lymphocytes in the inflammatory response in oral lichen 
planus and epithelial dysplasia.  
Alternate hypothesis: there are statistical significant differences between the presence 
and distribution of different subtypes of T-cells in the inflammatory response in oral lichen 


















MATERIALS AND METHODS 
This study protocol was registered, reviewed and approved by the University of North 
Carolina at Chapel Hill Institutional Review Board under the number 16-5988. All study 
procedures were performed in accordance with the Declaration of Helsinki and Research 
Committee Regulations. The study was designed as a pilot retrospective study. The 
population or sample consisted of archival tissue samples from the UNC Oral and Maxillofacial 
Pathology Laboratory. For this pilot study, 5 cases of each group were selected for testing.  
Specimen Selection 
Oral tissue samples received between July 1, 2005 to January 31, 2016, at the UNC 
at Chapel Hill Oral and Maxillofacial Pathology Laboratory that were diagnosed with Oral 
Lichen Planus or Epithelial Dysplasia were collected. A third group of specimens was selected 
composed of equivocal cases those with overlapping features between LP and OED (Figure 
1). Biopsy accession files and medical records from samples were reviewed for case selection. 
 





Inclusion and Exclusion Criteria 
Inclusion Criteria: 
For inclusion in the study, the specimens selected met the following criteria: 
1. Cases had sufficient tissue for additional analysis. 
2.  Lichen planus samples were from the buccal mucosa only.  
3. Epithelial dysplasia samples were from tongue, buccal mucosa or floor of 
mouth: 
i. Moderate to severe epithelial dysplasia: cytological and architectural 
premalignant changes limited to the lower two thirds of the total 
thickness of the epithelium.   
ii. A lichenoid inflammatory reaction in the upper connective tissue.  
4. Equivocal cases with overlapping features, were from buccal mucosa and 
lateral tongue. 
5. Samples were from subjects over 21 years of age. 
Exclusion Criteria: 
Any of the following was regarded as a criterion for exclusion from the study: 
1. Tissue samples from subjects with previous history of cancer of any type.  
2. Patients with documented prior history of treatment with steroids prior to the biopsy 
date 
3. History of underlying immunosuppression from any cause.  
4. Subjects under 21 years of age 
5. Subjects with prior history of radiation treatment to the head or neck. 
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Data Collection and Processing 
The hematoxylin and eosin slides were reviewed and the diagnosis confirmed by two 
board-certified oral and maxillofacial pathologists (RP, VM). After the final case selection, the 
paraffin blocks were selected and two unstained slides sectioned for immunofluorescence (IF) 
and immunohistochemistry (IHC) studies.  
Study Procedures 
Dual IF was carried out on the Bond fully-automated slide staining system (Leica 
Microsystems Inc., Norwell MA). CD4 and CD8 antibodies (catalog numbers NCL-L-CD4-368 
and NCL-L-CD8-4B11, respectively) were purchased from Leica Biosystems. Slides were 
deparaffinized in Bond dewax solution (AR9222), hydrated in Bond wash solution (AR9590) 
and sequentially stained for CD4 and CD8. Specifically, antigen retrieval for CD4 was 
performed for 20 min at 1000C in Bond-epitope retrieval solution 2 pH 9.0 (AR9640). After 
pretreatment, slides were incubated for 30 min with CD4 antibody (1:200) followed with Bond 
polymer (DS9390) and TSA Cy5 (PerkinElmer, Boston, MA). After completion of CD4 staining, 
a second round of antigen retrieval was performed for 10 min at 1000C in Bond-epitope 
retrieval solution 2 pH 9.0.  Slides were then incubated with the CD8 antibody (1:200, 30 min) 
which was detected with Alexa488 labeled goat anti-mouse secondary antibody (Invitrogen, 
Carlsbad, CA).  Nuclei were stained with Hoechst 33258 (Invitrogen, Carlsbad, CA). The 
stained slides were mounted with ProLong Gold antifade reagent (Molecular Probes, Inc. 
Eugene, OR 97402). 
Analysis of IF Images: 
Slides were scanned in the Aperio ScanScope FL (Leica Biosystems, Wetzlar, 
Germany) using a 20X objective and images were archived in TPL’s eSlide Manger database 




Figure 2.  Example of annotations made on IF/IHC slides. 
For all eSlides, Aperio ImageScope (Aperio ImageScope Version 12.3.2.8013; Leica 
Biosystems, Wetzlar, Germany) software was used to highlight two regions named Epithelium 
or Zone 1 and Connective Tissue or Layer 2. Images were annotated by the investigators 
based on H&E staining (Figure 2).  The criteria utilized for the annotation regions were as 
follows: 
1. The epithelial section was outlined following the contour of the basement membrane, 
involving all the layers of the epithelium and including inflammatory cells infiltrating 
through the basement membrane, extending to the surface of the stratum corneum.  
2. The connective tissue section involved included encircling the area immediately 
subjacent to the basement membrane.  
3. Any cells with double expression for CD4 and CD8 were excluded from analysis.  
Automated digital analysis of images was run separately in these two regions. Tissue 
Studio software (Tissue Studio version 2.5 with Tissue Studio Library version 4.2; Definiens 
Inc., Carlsbad CA), specifically, the Nuclei and Simulated Cells algorithm in the IF Portal, was 
used to detect and enumerate cells that co-expressed biomarkers of interest in the annotated 
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regions. Briefly, nuclei were digitally detected by the presence of Hoechst stain (nuclear 
counterstain).  From these nuclei, a cell simulation was performed – cell margins were grown 
out from nuclear boundaries (Figure 3).  For this data set, positivity thresholds for CD4 and 
CD8 were determined by measuring the average staining intensities both inside and outside 
simulated cells.  Measurements were made from a total of six regions from an algorithm 
training set that contained three of the sixteen images (15 cases of all three groups and 
control). The training set images were chosen to encompass the full range of staining 
intensities present in the entire analysis data set (images with high, medium, low or negative 
staining for CD4 and CD8).  Once thresholds were set, the algorithm evaluated each cell 
individually for the presence of CD4 and CD8. Cells that were negative for both markers or 
positive for CD4, CD8 and both CD4 and CD8 were enumerated by the algorithm.  Microsoft 
Excel 2013 was used to determine the percentage of cells that co-express each marker. 
 
Figure 3.  Graphic representation of the region analysis and cells classification made by the software (Zone 1: 
Epithelium; Zone 2: Connective Tissue) 
Formula’s for Co-Expression Percentage Determinations: 
% of CD4+ cells = (# CD4+ cells/Total cells) *100 
% of CD8+ cells = (# CD8+ cells/Total cells) *100 




% CD8+ cells that co-express CD4 = (# of cells that co-express CD4 and CD8/#CD8+ 
cells)*100 
Data Analysis 
A statistical software package (IBM Corp. Released 2013. IBM SPSS Statistics for 
Windows, Version 22.0. Armonk, NY: IBM Corp) was used to calculate confidence intervals 
(CI) in order to stablish an estimated difference between cell populations by layer analyzed.  
Statistical Analysis 
Confidence intervals and power statistical analysis were conducted on the preliminary 
data to establish significant different and the necessary sample to stablish a statistical 
significant difference. All data was entered into SPSS software (IBM Corp. Released 2013. 
IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp). Mean, standard 
deviation and 95% confidence intervals were computed for all continuous variables.  
Analysis of the Distribution of CD8+ T-cells in Lichen Planus vs Epithelial Dysplasia 
The second part of the study consisted of the analysis of the distribution of infiltrating 
CD8+ T-cells in the epithelial portions of all selected specimens.  Aperio ImageScope (Aperio 
ImageScope Version 12.3.2.8013; Leica Biosystems, Wetzlar, Germany) software was used 
to divide Zone 1, encircling the epithelium, into two different areas named upper half and lower 
half or basal area. The upper half was defined as the area between the stratum corneum and 
half the thickness of the epithelial layer. The lower half or basal area, was defined as the 
segment between the basal layer of the epithelium and a line drawn through the midpoint of 
the thickness of the epithelium (Figure 4). All focal areas with tangential sections were not 




Figure 4.  Example of analysis of distribution of CD8+ lymphocytes within epithelium or Zone 1. The yellow lines 
mark the epithelial thickness and the red line the approximate half of the region analyzed. 
 
The investigator then separated all the specimens with the following criteria:  
1. All the tissue sections with the majority of CD8+ cells concentrated in the basal 
layer of the epithelium were classified as Group A.  
2. The specimens with the majority of CD8+ cells scattered through the thickness 
of the epithelium, and mostly found in the upper half the Zone 1 were classified as Group B. 
All results were compared with the original diagnoses and hematoxylin and eosin 











The total number of cells and ratio of CD4+ and CD8+ T-cells by category in all tissue 
sections are summarized in Table 1. All the cells that the software identified on IHC and IF as 
double positive for CD4 and CD8 antibodies were excluded from the analysis to prevent false 
positive due to overlapping positivity of adjacent cells.  Although the presence of double 
positive CD4/CD8 T-cells in internal organs and peripheral tissue has been reported, flow 
cytometry seems to be the best way to identify them (53). Also, the published data is still 
controversial and currently little is known about their function and development.  
 
















1 29 36 2075 5594 2104 5630 1.4 0.6 98.6 99.4 
2 48 269 860 7928 908 8197 5.3 3.3 94.7 96.7 
3 424 4329 118 416 542 4745 78.2 91.2 21.8 8.8 
4 716 2652 1127 2085 1843 4737 38.8 56.0 61.2 44.0 
5 1511 12459 40 448 1551 12907 97.4 96.5 2.6 3.5 
6 573 212 2345 1848 2918 2060 19.6 10.3 80.4 89.7 
7 1826 11572 860 2125 2686 13697 68.0 84.5 32.0 15.5 
8 13 130 1105 3422 1118 3552 1.2 3.7 98.8 96.3 
9 1828 4487 905 1001 2733 5488 66.9 81.8 33.1 18.2 
10 167 5661 477 4108 644 9769 25.9 57.9 74.1 42.1 
11 957 1953 1474 1761 2431 3714 39.4 52.6 60.6 47.4 
12 0 3 2942 3672 2942 3675 0.0 0.1 100.0 99.9 
13 510 4513 253 1069 763 5582 66.8 80.8 33.2 19.2 
14 3060 3919 7095 1498 10155 5417 30.1 72.3 69.9 27.7 
15 69 469 2594 14606 2663 15075 2.6 3.1 97.4 96.9 
Table 1. Total number and ratio of CD4+ and CD8+ lymphocytes by zone analyzed. 
 
A graphic representation of the percentiles of quantified cells by zone and group are 




Figure 5.  Graphic representation of averages of percentages of cells counted by zone in all the specimens 
selected. 
 
CD4+/CD8+ Ratio in Oral Lichen Planus 
Zone 1:  
The average number of CD4+ cells infiltrating the epithelium in all cases of LP was 
545.6 cells, representing 44.2% of all CD4+ and CD8+ cells quantified in Zone 1. The average 
number of CD8+ cells was 844, accounting for 55.8%. The average ratio of CD4+/CD8+ cells 
infiltrating the epithelium in all cases of confirmed LP was 2:3 respectively.  
Zone 2:  
Regarding the cells present in the lichenoid infiltrate in Zone 2, the average amount of 
CD4+ cells in the connective tissue was 3949, accounting for 49.5% of all purely positive 
CD4+/CD8+ cells quantified. The average amount of CD8+ cells was 3294.2 representing 
50.5% of cells quantified. The ratio of CD4+/CD8+ cells in the Zone 2 was 1:2 respectively.   
CD4+/CD8+ Ratio in Epithelial Dysplasia  
Zone 1: 
Epithelium Connective Tissue Epithelium Connective Tissue
CD4+ Cells CD8+ Cells
Lichen Planus 44.2 49.5 55.8 50.5
Epithelial Displasia 36.3 47.9 62.4 52.1
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The average amount of CD4+ T-lymphocytes encountered in all cases with confirmed 
moderate to severe epithelial dysplasia was 881.4 which represents 36.3% of all cells. The 
average of CD8+ cells was 1138.4, accounting for 62.4%. This constitutes a CD4+/CD8+ ratio 
of 1:2 respectively.  
Zone 2: 
The average of CD4+ T-lymphocytes present in the underlying lichenoid infiltrate in all 
confirmed OED was 4412.4 which represents 62.4% of all immunoreactive T-cells. The CD8+ 
cell average in Zone 2 was 2500.8 which represents a 52.1% of all CD4+/CD8+ cells, resulting 
in a 2:1 ratio.  
Statistical Analysis 
For the most part, the CD4+/CD8+ T-cell ratio was very similar for both oral lichen 
planus and epithelial dysplasia. However, a slight increase of cytotoxic CD8+ T-cells was 
encountered in Zone 1 and 2 in the OED group.  
Power Analysis: 
With the use of a statistical software package (IBM Corp. Released 2013. IBM SPSS 
Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp), statistical power was calculated 
to detect the significance that could be achieved for the given sample size, and plausible 
population parameters for the statistical model judged appropriate for the research questions. 
The standard deviation of CD4+ cells found infiltrating Zone 1 for the combination of LP and 
OED groups, was 739.4; for CD8+ cells was 764.3. It was calculated that a sample size of 76 
specimens would be necessary to significantly demonstrate a difference in the increase of 
CD8+ cells infiltrating and underlying epithelial dysplasia when compared to lichen planus 
confirmed specimens.  
Power was estimated as the proportion of replication of results in which the null 
hypothesis is correctly rejected for alpha = .05 (type I error). Power was calculated greater or 
equal to .80. 
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Confidence Intervals:  
Confidence intervals (CI) were performed to identify a plausible range of the true 
population value by accounting for distributional assumptions. Confidence level was set at 




Lichen Planus - Zone 1 (Epithelium) 
Level Quantile 95% Confidence Limits Distribution Free  
50% Median 424 29 1511 
Lichen Planus - Zone 2 (Connective Tissue) 
50% Median  2652 36 12459 
Epithelial Dysplasia - Zone 1 (Epithelium) 
50% Median 573 13 1828 
Epithelial Dysplasia - Zone 2 (Connective Tissue) 
50% Median  4487 130 11572 
CD8+ T-cells 
Lichen Planus - Zone 1 (Epithelium) 
Level Quantile 95% Confidence Limits Distribution Free 
50% Median 860 40 2075 
Lichen Planus - Zone 2 (Connective Tissue) 
50% Median 2085 416 7928 
Epithelial Dysplasia - Zone 1 (Epithelium) 
50% Median 905 477 2345 
Epithelial Dysplasia - Zone 2 (Connective Tissue) 
50% Median 2125 1001 4108 
Table 2.  Confidence Intervals (median about percentiles) calculated per zone analyzed. 
 
Confidence Intervals in Lichen Planus vs Epithelial Dysplasia in Zone 1 
Although power analysis estimated statistical significance between groups, confidence 
intervals were calculated to identify possible difference between the CD4+/CD8+ ratio. The 





Figure 6.  Overlapping confidence intervals (95%) – CD4+ and CD8+ cells infiltrating the epithelium (Zone 1) by 
group. 
 
Confidence Intervals in the Lichen Planus vs Epithelial Dysplasia in Zone 2 
 
Figure 7. Overlapping confidence Intervals (95%) – CD4+ and CD8+ cells underlying the epithelium (connective 
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Analysis of the Distribution of CD8+ T-cells in Lichen Planus vs Epithelial Dysplasia 
The full results of the morphological distribution of CD8+ cells are summarized in table 
3. The biggest difference in the comparison of oral lichen planus with epithelial dysplasia was 
the pattern of infiltration of CD8+ cells. 
 
Diagnosis Case Observations 
LP 1 CD8+ cells in basal layer and below epithelium or Layer 1 
LP 2 CD8+ cells below epithelium and infiltrating basal layer of epithelium 
LP 3 CD8+ cells below epithelium 
LP 4 CD8+ cells below epithelium and infiltrating basal layer of epithelium 
LP 5 CD8+ cells below epithelium and infiltrating basal layer of epithelium 
Dysplasia 6 Multiple CD8+ cells found in upper half of the epithelium 
Dysplasia 7 Atrophic epithelium, minimal amount of CD8+ cells in upper half 
Dysplasia 8 CD8+ cells found in upper half 
Dysplasia 9 Upper half of epithelium, some infiltrating normal appearing epithelium 
Dysplasia 10 CD8+ in upper half throughout later 1, and infiltrating salivary gland ducts 
Table 3. Distribution of CD8+ cells in the Epithelium in Oral Lichen Planus vs Epithelial Dysplasia. 
 
The greatest infiltration of CD8+ T-cells was observed in the OED group, where the 
cytotoxic cells appeared to infiltrate the dysplastic epithelium and follow the atypical features. 
Since all the samples selected for this group consisted of moderate to severe dysplasia, the 
CD8+ cells were localized to the area from the basal layer to the upper half of the epithelium 
















This study attempted to evaluate the population of T-cells comprising the inflammatory 
lichenoid infiltrate underlying the epithelium in oral lichen planus and epithelial dysplasia, 
specifically regarding the quantity and distribution of two major subtypes of lymphocytes.  
Phenotype of Inflammatory Cells in Oral Lichen Planus 
Established oral lichen planus lesions are typically found to contain T-cells with alpha-
beta receptors, including CD4+ and CD8+, designated helper and cytotoxic respectively. Both 
subtypes can be found within the epithelium and lamina propria infiltrates, and are involved in 
a type 1 immune response, where CD4+ T-cells produce Th1 soluble factors. This response 
likely includes cell-mediated cytotoxicity, as CD8+ T-cells have been described to be localized 
to the epithelial-connective tissue interface and sometimes adjacent to apoptotic 
keratinocytes(6). In our study, the majority of CD4+ cells were found in the connective tissue 
underlying the involved epithelium, and CD8+ cytotoxic cells were mostly found infiltrating the 
keratinocytes of the basal layer (Figure 8). Khan et al. (2003) reported that CD4+ helper T-
cells are prominent in early lesions, mainly in the superficial connective tissue with occasional 
cells in the epithelium (Figure 9), which is also consistent with the study of Firth et al (2015)(10) 
study, where regulatory T-cells expressing FoxP3 and IL-7, such as helper CD4+ lymphocytes 




Figure 8.  Distribution of CD4+ and CD8+ lymphocytes detected by IF/IHC. Blue – Nuclei stained with Hoechst. 




Figure 9.  Presence of CD4+ lymphocytes mainly in the connective tissue and basal membrane some. Red – 
CD4+ cells (400x magnification). 
Also, most of the intraepithelial lymphocytes were CD8+ cells and the proportion of 
these lymphocytes was higher in the superficial than the deeper lamina propria, in consonance 
with what has been previously established in the literature(54). CD8+ T-lymphocytes were 
usually found in close proximity to the epithelial basement membrane. This finding correlates 
with the studies of Khan et al. (2003), where the presence of CD8+ lymphocytes in oral lichen 
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planus, were associated with basal epithelial cells undergoing apoptosis(13,15). It has been 
also described, that the presence of activated CD8+ cells expressing human leukocytic 
antigen surface antigen, is detected not only close to damaged epithelial cells but also to the 
basement membrane and epithelial areas of erosion (55). No significant differences in the 
ratio of CD4+/CD8+ (2:3) in the infiltrating and underlying t-lymphocytes were encountered in 
the present study.   
The trigger for keratinocyte apoptosis in oral lichen planus is unknown. However, the 
localization of CD8+ cells can be explained by the previously mentioned studies and by 
Sugerman et al. (2000), who reported that CD8+ lesional cells recognize antigen associated 
MHC class I on lesional keratinocytes. Following antigen recognition and activation, CD8+ 
cytotoxic T-cells trigger keratinocyte apoptosis, resulting in the clinical and histological 
appearance of LP (16).  
Phenotype of the Inflammatory Infiltrate in Oral Epithelial Dysplasia with Lichenoid Features  
In the oral cavity, the most common lesions clinically recognized as potentially 
malignant are leukoplakia and erythroplakia, but it is also apparent that as many as 50% of 
oral SCCs arise from apparently clinically normal mucosa (56). The prognostic significance of 
an individual lesion is difficult to determine.  None of the currently available molecular markers 
have proved to be prognostically significant nor have yet been evaluated in large prospective 
studies. At present, therefore, the diagnosis and grading of OED is based on a combination of 
architectural and cytological changes, but these are subjective and there is considerable 
variability between pathologists in grading of the lesions. In a study by Fitzpatrick et al. (2014), 
29% of 352 OED observed, have lichenoid features, which consisted of a band-like 
inflammatory cell infiltrate underlying and infiltrating the epithelium and basal cell 
degeneration(29). This finding is consistent with all the specimens encountered in our study, 




Figure 10.  Hematoxylin and Eosin tissue section of a sample with moderate to severe epithelial dysplasia. 
(Magnification 400X) 
 
As far as the CD4+/CD8+ ratio of cells underlying moderate to severe OED was 
concerned, no statistically significant differences were encountered in any of the layers. There 
was a moderate increase in the inflammatory cell infiltrate in the OED group compared to oral 
LP. The infiltrates of both of the CD8+ and CD4+ cells were significantly greater in number 




Figure 11.  CD4+ and CD8+ cell infiltrate within Zone 1. Yellow line highlights the epithelium-connective tissue 
interphase. 
 
CD4+/CD8+ cell ratio in Oral Lichen Planus vs Epithelial Dysplasia with Lichenoid Features 
Regarding the CD4+/CD8+ ratio, the CD8+ lymphocytes were found to be slightly 
increased in comparison to the CD4+ cell population in OED, whereas the ratio was slightly 
tipped in favor of CD4+ lymphocytes in LP. This suggests an important change in the behavior 
of the inflammatory infiltrate from a cytotoxic activity that is aimed to eliminate the lesion in 





Figure 12.  Graphic representation of averages of percentages of cells present in Layer 1 and 2 of oral lichen 
planus vs dysplasia. 
 
An important change can be appreciated in the date for premalignant lesions where 
the CD4+/CD8+ cell ratio changes from the position of CD8+ lymphocytes. It is already known 
CD4+/CD8+ cell infiltrate is significantly higher in moderate to severe dysplasia in comparison 
with benign lesions and in SCC (9,40). This can be explained by the relationship between 
immunosurveillance and tumor progression, in which carcinogenesis results from crosstalk of 
cancer-cell-intrinsic factors and host immune system or “cell-intrinsic” effects(57). Hirota et al. 
(1990), also demonstrated an increased number of T-helper cells over T-cytotoxic cells within 
the T-cell subpopulation of oral SCC lesions. The above suggests an overall switching of the 
immune response in favor of pro-tumor immunity dominated by a CD4+ cell population that 
might help in tumor initiation and progression as suggested by Strauss et al. (2007). Further 
studies need to be conducted to identify the subpopulations of CD4+ cells that are directly 
responsible for such increase in the CD8+ population.  
There was no statistically significant difference between the numbers of cells 
encountered in the different zones analyzed in our study.  This indicates that the CD4+/CD8+ 
T-cell ratio is similar between both lesions and, therefore cannot be used to differentiate them. 
Epithelium Connective Tissue Epithelium Connective Tissue
CD4+ Cells CD8+ Cells
Lichen Planus 44.2 49.5 55.8 50.5
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However, the localization of CD8+ cells infiltrating the epithelium can be useful in 
differentiating these dysplastic lesions with lichenoid features and LP.  
In our study, in all the cases with moderate to severe epithelial dysplasia, a striking 
population of CD8+ lymphocytes were found following the dysplastic changes in the epithelial 
zone. Since cytotoxic CD8+ cells will try to eliminate the cells undergoing malignant 
transformation within the epithelial layer, it makes sense that in moderate to severe OED, 
these types of inflammatory cells follow the malignant changes throughout the thickness of 
this morphological and cytological changes within the tissue. For this reason, the localization 
of CD8+ cells could be used to differentiate OED and LP in equivocal cases.   Of course, more 
proven cases are necessary, along with clinical follow-up of the patient’s progression to 
confirm this theory. Also, tangential sectioning of tissue can obscure the true position of these 
























The inflammatory component of the oral cavity is a complex system that, at this point 
in time, is still not well understood, especially with respect to potentially premalignant mucosal 
lesions. The diagnostic dilemma addressed in this study may be eventually solved by 
identifying cells with specific functions within the inflammatory population that can be used to 
track early malignant changes within the mucosal epithelium. However, there is no specific 
marker or panel of markers available yet that allow reliable prediction of malignant 
transformation of leukoplakia in the oral cavity. Further studies regarding specific subtypes of 
CD4+ and CD8+ T-cells are necessary to distinguish between OLP and OED and reliably 
predict the malignant transformation of OED and those equivocal cases previously mentioned.  
Results of this study suggests that the distribution of CD8+ by immunohistochemistry 
can help in differentiating moderate/severe oral epithelial dysplasia, from LP and potentially 
other inflammatory conditions. Further research with more cases in comparison with diverse 
inflammatory models, is necessary to establish conclusive results, which will be part of the 
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